Skip to main content
PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · IEX Real-Time Price · USD
61.87
-2.53 (-3.93%)
At close: Jul 26, 2024, 4:00 PM
61.23
-0.64 (-1.03%)
After-hours: Jul 26, 2024, 4:24 PM EDT

PROCEPT BioRobotics Revenue

PROCEPT BioRobotics had revenue of $44.54M in the quarter ending March 31, 2024, with 82.51% growth. This brings the company's revenue in the last twelve months to $156.33M, up 83.44% year-over-year. In the year 2023, PROCEPT BioRobotics had annual revenue of $136.19M with 81.55% growth.

Revenue (ttm)
$156.33M
Revenue Growth
+83.44%
P/S Ratio
20.64
Revenue / Employee
$249,722
Employees
626
Market Cap
3.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023136.19M61.18M81.55%
Dec 31, 202275.01M40.54M117.60%
Dec 31, 202134.47M26.76M346.72%
Dec 31, 20207.72M1.55M25.09%
Dec 31, 20196.17M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amedisys 2.25B
GoodRx Holdings 764.16M
Azenta 651.76M
Inari Medical 520.66M
Axonics 387.14M
Denali Therapeutics 295.39M
Twist Bioscience 277.49M
Arcellx 131.66M
Revenue Rankings

PRCT News

More News